This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $300 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoLive In-Person Event: December 4 - 8, 2022

Vaughn Smider, M.D., Ph.D.
President at Applied Biomedical Science Institute


Dr. Smider is the founder and President of the Applied Biomedical Science Institute, and an adjunct faculty at Scripps Research. His research includes understanding antibody diversity, structure, and function, and includes both basic research and applied therapeutic and technology development projects. He received his M.D., and Ph.D. degrees from Stanford University and is a founder and consultant to several biotechnology companies working on novel biologics platforms.

Agenda Sessions

  • Co-Chairs’ Remarks

  • Ultralong CDR3-based Knobs: The Smallest Antibody Fragment